Company Filing History:
3 out of 154 
3 out of 5,081 
3 out of 1,743 
Years Active: 2000-2012
Title: Jacky Roger: Innovator in Cancer Therapy
Introduction
Jacky Roger is a notable inventor based in Villecresnes, France. He has made significant contributions to the field of cancer therapy and diagnosis, holding a total of four patents. His work focuses on innovative compounds that aim to improve treatment options for cancer patients.
Latest Patents
Jacky Roger's latest patents involve the use of a non-toxic B subunit of Shiga toxin mutant as a vector for diagnostic products or drugs targeting over-expressing GB3 receptor cells. These compounds are designed to enhance tumor diagnosis and drug delivery to GB3 expressing tumors. The formula for these compounds is represented as STxB-Z(n)-Cys-Y(m)-T, showcasing his commitment to advancing cancer treatment methodologies.
Career Highlights
Throughout his career, Jacky Roger has worked with prestigious institutions such as Institut Curie and the Centre National de la Recherche Scientifique. His experience in these organizations has allowed him to collaborate with leading experts in the field, further enhancing his research and innovation capabilities.
Collaborations
Jacky Roger has collaborated with notable colleagues, including Ludger Johannes and David Grierson. These partnerships have contributed to the development of his groundbreaking inventions and have fostered a collaborative environment for scientific advancement.
Conclusion
Jacky Roger's innovative work in cancer therapy exemplifies the impact of dedicated inventors in the medical field. His patents and collaborations reflect a commitment to improving patient outcomes through advanced research and development.